Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002287029> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2002287029 endingPage "112" @default.
- W2002287029 startingPage "107" @default.
- W2002287029 abstract "Neovascularization observed in the synovial tissue of rheumatoid arthritis is essential for the nutrition of proliferating synovial tissue; therefore, attempts have recently been made to use angiogenesis-inhibiting drugs for the treatment of arthritis. Endostatin is a C-terminal noncollagen-region fragment of type XVIII collagen, and has a potent angiogenesis-inhibiting effect. Recently, we have systemically administered endostatin to arthritic mice to investigate its arthritis-inhibiting effect. We induced the development of arthritis in 6-week-old female Balb/c mice by administrating four kinds of monoclonal anti-type II collagen antibodies followed by LPS 3 days later. Three endostatin groups of mice received 0.2 mg/kg/day, 2 mg/kg/day, or 10 mg/kg/day for 13 days before the development of arthritis, and a control group received PBS. Arthritis was evaluated by arthritis scores and hind paw thickness. In addition, the left and right foot joints were collected on the 22nd day of administration of monoclonal anti-type II collagen antibody, and histopathological preparations were made. Arthritis scores and hind paw thickness were lower in the 10 mg/kg/day group than in the control group. Histopathological examination showed that pannus formation and bone destruction were suppressed in the endostatin group compared with the control group. No severe side effects occurred in the endostatin-administered mice. These results suggest that endostatin is a promising new antiarthritic drug with few side effects and a novel mechanism of action." @default.
- W2002287029 created "2016-06-24" @default.
- W2002287029 creator A5008024982 @default.
- W2002287029 creator A5077368934 @default.
- W2002287029 date "2004-01-01" @default.
- W2002287029 modified "2023-10-18" @default.
- W2002287029 title "Arthritis-inhibiting effect of endostatin" @default.
- W2002287029 cites W1691912414 @default.
- W2002287029 cites W1956271787 @default.
- W2002287029 cites W1968111489 @default.
- W2002287029 cites W1984496091 @default.
- W2002287029 cites W1997471955 @default.
- W2002287029 cites W2005294501 @default.
- W2002287029 cites W2034672236 @default.
- W2002287029 cites W2038003822 @default.
- W2002287029 cites W2050061160 @default.
- W2002287029 cites W2078868629 @default.
- W2002287029 cites W2084272592 @default.
- W2002287029 cites W2085396553 @default.
- W2002287029 cites W2108850617 @default.
- W2002287029 cites W2131798870 @default.
- W2002287029 cites W2151619744 @default.
- W2002287029 cites W2157642143 @default.
- W2002287029 cites W2168014904 @default.
- W2002287029 cites W2419487429 @default.
- W2002287029 doi "https://doi.org/10.2492/jsir.24.107" @default.
- W2002287029 hasPublicationYear "2004" @default.
- W2002287029 type Work @default.
- W2002287029 sameAs 2002287029 @default.
- W2002287029 citedByCount "0" @default.
- W2002287029 crossrefType "journal-article" @default.
- W2002287029 hasAuthorship W2002287029A5008024982 @default.
- W2002287029 hasAuthorship W2002287029A5077368934 @default.
- W2002287029 hasBestOaLocation W20022870291 @default.
- W2002287029 hasConcept C126322002 @default.
- W2002287029 hasConcept C142724271 @default.
- W2002287029 hasConcept C203014093 @default.
- W2002287029 hasConcept C2777077863 @default.
- W2002287029 hasConcept C2777575956 @default.
- W2002287029 hasConcept C2777746085 @default.
- W2002287029 hasConcept C2778271429 @default.
- W2002287029 hasConcept C2780394083 @default.
- W2002287029 hasConcept C2781013607 @default.
- W2002287029 hasConcept C71924100 @default.
- W2002287029 hasConcept C75920679 @default.
- W2002287029 hasConcept C98274493 @default.
- W2002287029 hasConceptScore W2002287029C126322002 @default.
- W2002287029 hasConceptScore W2002287029C142724271 @default.
- W2002287029 hasConceptScore W2002287029C203014093 @default.
- W2002287029 hasConceptScore W2002287029C2777077863 @default.
- W2002287029 hasConceptScore W2002287029C2777575956 @default.
- W2002287029 hasConceptScore W2002287029C2777746085 @default.
- W2002287029 hasConceptScore W2002287029C2778271429 @default.
- W2002287029 hasConceptScore W2002287029C2780394083 @default.
- W2002287029 hasConceptScore W2002287029C2781013607 @default.
- W2002287029 hasConceptScore W2002287029C71924100 @default.
- W2002287029 hasConceptScore W2002287029C75920679 @default.
- W2002287029 hasConceptScore W2002287029C98274493 @default.
- W2002287029 hasIssue "2" @default.
- W2002287029 hasLocation W20022870291 @default.
- W2002287029 hasOpenAccess W2002287029 @default.
- W2002287029 hasPrimaryLocation W20022870291 @default.
- W2002287029 hasRelatedWork W1996686377 @default.
- W2002287029 hasRelatedWork W2002287029 @default.
- W2002287029 hasRelatedWork W2034672236 @default.
- W2002287029 hasRelatedWork W2096868396 @default.
- W2002287029 hasRelatedWork W2163208874 @default.
- W2002287029 hasRelatedWork W2166237193 @default.
- W2002287029 hasRelatedWork W2273211921 @default.
- W2002287029 hasRelatedWork W2319770629 @default.
- W2002287029 hasRelatedWork W2354196540 @default.
- W2002287029 hasRelatedWork W4211033043 @default.
- W2002287029 hasVolume "24" @default.
- W2002287029 isParatext "false" @default.
- W2002287029 isRetracted "false" @default.
- W2002287029 magId "2002287029" @default.
- W2002287029 workType "article" @default.